MED-EL announces FDA approval for the new rechargeable DaCapo battery and charging system

Innsbruck, Austria, 2008-03-24

MED-EL has received approval by the US Food and Drug Administration for its new rechargeable DaCapo battery and charging system.

The DaCapo system was developed for the MED-EL OPUS 1, OPUS 2 and TEMPO+ speech processors. MED-EL speech processors continue to be the lightest and slimmest available. The DaCapo system additionally reduces the weight by another 20% without limiting performance.

DaCapo is an environmentally friendly and very convenient alternative to the existing battery options. The system is shipped with a charging unit and three PowerPacks, rechargeable batteries each lasting for 10-12 hours. It is compatible with most FM systems and other external hearing devices (e.g. Bluetooth® with OPUS 2). DaCapo is available in all six frame colors for a perfect match with existing MED-EL speech processor colors.